Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 10.7 Cr.
- Current Price ₹ 3.35
- High / Low ₹ 6.10 / 2.55
- Stock P/E
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE -0.10 %
- ROE -0.10 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.20 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 25.9%
- Company has a low return on equity of 10.3% over last 3 years.
- Company has high debtors of 21,097 days.
- Promoter holding has decreased over last 3 years: -10.8%
- Working capital days have increased from 11,249 days to 33,416 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | 39.81 | 0.20 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| 0.57 | 0.61 | 0.53 | 8.93 | 31.53 | 0.26 | |
| Financing Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 | -0.06 |
| Financing Margin % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% | -30.00% |
| 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -0.05 | |
| EPS in Rs | 0.16 | 2.58 | -0.02 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 17% |
| 3 Years: | -54% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 | 32.02 |
| Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 | 18.51 |
| Borrowing | 3.42 | 3.42 | 3.42 | 10.91 | 0.02 | 0.01 |
| 0.23 | 0.25 | 0.27 | 0.02 | 0.02 | 0.03 | |
| Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.57 |
| 0.52 | 0.49 | 0.45 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 | 0.00 |
| 3.97 | 4.57 | 4.51 | 16.89 | 50.61 | 50.56 | |
| Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.57 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -13.46 | -25.48 | 0.11 | ||||
| 0.00 | -0.01 | 0.00 | ||||
| 12.58 | 25.46 | 0.00 | ||||
| Net Cash Flow | -0.88 | -0.03 | 0.11 | |||
| Free Cash Flow | -13.46 | -25.49 | 0.11 | |||
| CFO/OP | -2,588% | -308% | -183% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| ROE % | -6.93% | -2.70% | -3.33% | 8.72% | 29.25% | -0.10% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number ・Standalone data |
|
||||||||
| Current Ratio Ratio ・Standalone data |
|||||||||
| Debt-Equity Ratio Ratio ・Standalone data |
|||||||||
| Trade Receivables Turnover Ratio Ratio ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
3 Jun - Mr. Abdulaziz Fakirmamad Luhar appointed Additional Non-Executive Director from 03 June 2026.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Shrydus Industries files FY26 Secretarial Compliance Report; notes penalties of ₹11,800, ₹1,23,900 and ₹88,500.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 May - Newspaper Publication for Audited financial result for the quarter and year ended March 31, 2026
- Audited Standalone And Consolidated Financial Result For The Quarter And Year Ended March 31, 2026 22 May
-
Board Meeting Outcome for Outcome Of The Board Meeting
22 May - Board approved audited standalone and consolidated results for quarter and year ended March 31, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector